Literature DB >> 25054761

Polypoid melanoma and superficial spreading melanoma different subtypes in the same lesion.

Renato Shintani Hikawa1, Eliza Sayuri Kanehisa1, Mílvia Maria Simões e Silva Enokihara1, Mauro Yoshiaki Enokihara1, Sérgio Henrique Hirata1.   

Abstract

Melanoma is a malignant melanocytic neoplasm with high mortality rate, and steadily and universally increasing incidence rates. Polypoid melanoma is considered an exophytic variant of the nodular subtype. The incidence of polypoid melanoma is extremely variable, most likely because of the different criteria used for its characterization. We presented a rare case of polypoid melanoma and superficial spreading melanoma in the same lesion.

Entities:  

Mesh：

Year:  2014        PMID： 25054761      PMCID： PMC4148288          DOI： 10.1590/abd1806-4841.20142802

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


  9 in total

1.  A clinical evaluation of malignant melanoma.

Authors:  W R VOGLER; G D PERDUE; S A WILKINS
Journal:  Surg Gynecol Obstet       Date:  1958-05

2.  Polypoid melanoma is not rare.

Authors:  H M Shaw; J F Thompson
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

3.  The classification of malignant melanoma and its histologic reporting.

Authors:  V J McGovern; M C Mihm; C Bailly; J C Booth; W H Clark; A J Cochran; E G Hardy; J D Hicks; A Levene; M G Lewis; J H Little; G W Milton
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

Review 4.  Polypoid melanoma: a virulent variant of nodular melanoma. Report of three cases and literature review.

Authors:  H Plotnick; N Rachmaninoff; H J VandenBerg
Journal:  J Am Acad Dermatol       Date:  1990-11       Impact factor: 11.527

Review 5.  Pedunculated malignant melanoma.

Authors:  K Cutler; P Chu; M Levin; M Wallack; P C Don; J M Weinberg
Journal:  Dermatol Surg       Date:  2000-02       Impact factor: 3.398

6.  [Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study].

Authors:  H Breuninger; C Köhler; H Drepper; B Bastian; E B Bröcker; J Göhl; W Groth; P Hermanek; W Hohenberger; A Lippold
Journal:  Hautarzt       Date:  1994-08       Impact factor: 0.751

7.  Immediate local and regional recurrence after the excision of a polypoid melanoma: tumor dormancy or tumor activation?

Authors:  Vincenzo De Giorgi; Daniela Massi; Gianni Gerlini; Francesca Mannone; Elena Quercioli; Paolo Carli
Journal:  Dermatol Surg       Date:  2003-06       Impact factor: 3.398

8.  Prognostic significance of a polypoid configuration in malignant melanoma.

Authors:  V J McGovern; H M Shaw; G W Milton
Journal:  Histopathology       Date:  1983-09       Impact factor: 5.087

9.  Final version of 2009 AJCC melanoma staging and classification.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544
  9 in total
  2 in total

1.  The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.

Authors:  Ajit J Nirmal; Zoltan Maliga; Tuulia Vallius; Sandro Santagata; Peter K Sorger; Brian Quattrochi; Alyce A Chen; Connor A Jacobson; Roxanne J Pelletier; Clarence Yapp; Raquel Arias-Camison; Yu-An Chen; Christine G Lian; George F Murphy
Journal:  Cancer Discov       Date:  2022-06-02       Impact factor: 38.272

2.  Cauliflower-like exophytic mass on the skin: polypoid melanoma. Clinical, dermoscopic, and histologic features.

Authors:  Ambra Di Altobrando; Annalisa Patrizi; Emi Dika; Francesco Savoia
Journal:  An Bras Dermatol       Date:  2020-09-11       Impact factor: 1.896
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.